Related Experiment Video
Updated: May 17, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
Published on: October 28, 2022
Serum heme oxygenase-1 as a marker of lung function decline in patients with chronic silicosis
Takashi Sato1, Yoshiaki Saito, Satoshi Inoue
1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. takashisato1220@gmail.com
Objective:
To identify predictive factors of excess decline in forced expiratory volume in one second (FEV1) in patients with chronic silicosis.
Methods:
Forty-six male patients enrolled in 2004 were screened and received pulmonary function tests.
Results:
Among the 33 included patients, 12 were categorized as rapid decliners (reduction in FEV1 > 60 mL/yr). The mean level of serum heme oxygenase-1 (HO-1), a marker of oxidative stress, was significantly lower in rapid decliners than in normal decliners (P = 0.002). Logistic regression analysis revealed that serum HO-1 was a factor affecting clinically important decline in FEV1 (odds ratio = 0.52; 95% confidence interval, 0.31 to 0.88) independent of the effects of age, height, weight, smoking, exposure status, and C-reactive protein.
Conclusions:
Serum HO-1 may be a predictor of lung function decline in silicosis patients.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
